The A to Z of new hepatotropic agents: human hepatitis viruses and monkey business (Q41623179)

5 October 2017

1 reference

title

The A to Z of new hepatotropic agents: human hepatitis viruses and monkey business (English)

1 reference

5 October 2017

Mason AL

1

1 reference

5 October 2017

Perrillo RP

series ordinal

2

1 reference

5 October 2017

publication date

1 September 1996

1 reference

5 October 2017

published in

Liver Transplantation

1 reference

5 October 2017

volume

2

1 reference

5 October 2017

issue

5

1 reference

5 October 2017

page(s)

395-405

1 reference

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020512

Studies on the transmission of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passages, and description of liver lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020512

Specific neutralization of human hepatitis type A in marmoset monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020512

Cloning the differences between two complex genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020512

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020512

Identification of two flavivirus-like genomes in the GB hepatitis agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020512

Basic local alignment search tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020512

Molecular and serologic analysis in the transmission of the GB hepatitis agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020512

Isolation of novel virus-like sequences associated with human hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020512

Syncytial giant-cell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxoviral features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020512

Ribavirin for syncytial giant cell hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020512

Seroepidemiology of water-borne hepatitis in India and evidence for a third enterically-transmitted hepatitis agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020512

Retrovirus-like particles in hepatocytes of patients with transfusion-acquired non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020512

Detection of a human intracisternal A-type retroviral particle antigenically related to HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020512

Acquired immunodeficiency syndrome cholangiopathy: spectrum of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020512

The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020512

Postinfantile giant-cell transformation in hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020512

Persistent measles virus genome in autoimmune chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020512

Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020512

Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020512

What causes fulminant hepatic failure of unknown etiology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020512

Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020512

Toga-like virus as a cause of fulminant hepatitis attributed to sporadic non-A, non-B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020512

Toga virus-like particles in acute liver failure attributed to sporadic non-A, non-B hepatitis and recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020512

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020512

Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020512

Non-A, Non-B Hepatitis Unrelated to the Hepatitis C Virus (Non-ABC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020512

Serial passage of West-European sporadic non-A non-B hepatitis in rhesus monkeys by inoculation with fecal extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500020512

21 January 2018

Identifiers

DOI

10.1002/LT.500020512

1 reference

5 October 2017

1 reference